You are here : Version française > Valorisation > Projets 'Preuve de Concept'
-
Partager cette page
'Proof of Concept' Projects
Ecofect aims to decipher the functioning of infectious diseases from molecular mechanisms to dynamic and evolutive processes within populations, communities of hosts or infectious agents. The LabEx long-term goal is to propose new innovative fighting strategies to better control infections from the individual level to host populations. Thanks to the 'Proof of concepts' (POC) call for propoals (now closed), Ecofect wanted to support advanced projects consolidating existing scientific data and technological expertise and having a genuine potential for translational applications. The three following POC projects have started in 2017:
NANOBLADES Project
The NANOBLADES project develops an innovative protocol allowing the delivery of CRISPR / Cas9 machinery by pseudo viral particles.
Project leaders:
Théophile Ohlmann & Emiliano Ricci - CIRI, Lyon
Els Verhoeyen, François-Loïc Cosset - CIRI, Lyon
Contact: Théophile Ohlmann - Email
Project leaders:
Théophile Ohlmann & Emiliano Ricci - CIRI, Lyon
Els Verhoeyen, François-Loïc Cosset - CIRI, Lyon
Contact: Théophile Ohlmann - Email
MOVEPAC Project
The MOVEPAC project develops a stable and immunogenic vaccine based on the use of a Mopeia disabled arenavirus.
Project leaders:
Sylvain Baize - CIRI, Pasteur Institute, Lyon
Hervé Raoul - P4 Jean Mérieux Laboratory, Lyon
Contact: Sylvain Baize - Email
Project leaders:
Sylvain Baize - CIRI, Pasteur Institute, Lyon
Hervé Raoul - P4 Jean Mérieux Laboratory, Lyon
Contact: Sylvain Baize - Email
ViroStop Project
The ViroStop project develops anti-fusion peptide inhibitors against the measles virus.
Project leaders:
Branka Horvat - CIRI, Lyon
Matteo Porotto - Columbia University Medical Center, New York, USA
Contact: Branka Horvat - Email
Project leaders:
Branka Horvat - CIRI, Lyon
Matteo Porotto - Columbia University Medical Center, New York, USA
Contact: Branka Horvat - Email